Prevalence of ICA-12 and other autoantibodies in north Indian patients with early-onset diabetes

Tandon, N. ; Shtauvere-Brameus, A. ; Hagopian, W. A. ; Sanjeevi, C. B. (2006) Prevalence of ICA-12 and other autoantibodies in north Indian patients with early-onset diabetes Annals of the New York Academy of Sciences, 958 (1). pp. 214-217. ISSN 0077-8923

Full text not available from this repository.

Official URL: http://onlinelibrary.wiley.com/doi/10.1111/j.1749-...

Related URL: http://dx.doi.org/10.1111/j.1749-6632.2002.tb02972.x

Abstract

This study attempts to assess the prevalence of various autoantibodies in early-onset diabetics in northern India, with emphasis on antibodies against glutamic acid decarboxylase (GAD65), IA-2, ICA-12, 21-hydroxylase (21-OH) and Tissue Transglutaminase (TTG). GAD65 and IA-2 antibodies were found to be present in approximately 26% of cases of type 1 diabetes. A subset of patients clinically diagnosed to have MMDM appears to have an autoimmune etiology, with more than 20% showing serpositivity for IA-2 antibodies. Antibodies against ICA-12 were prevalent in both type 1 diabetes and MMDM. Approximately one of seven patients with type 1 diabetes showed erological evidence of celiac disease.

Item Type:Article
Source:Copyright of this article belongs to John Wiley and Sons Inc.
ID Code:107089
Deposited On:23 Jun 2017 06:40
Last Modified:23 Jun 2017 06:41

Repository Staff Only: item control page